Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of the Efficacy of Irbesartan/Hydrochlorothiazide 300/25 mg Versus Valsartan/Hydrochlorothiazide 160/25 mg Using Home Blood Pressure Monitoring in the Treatment of Mild to Moderate Hypertension

NCT00500604 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00500604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00500604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of the Efficacy of Irbesartan/Hydrochlorothiazide 300/25 mg Versus Valsartan/Hydrochlorothiazide 160/25 mg Using Home Blood Pressure Monitoring in the Treatment of Mild to Moderate Hypertension
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
January 31, 2010
Enrollment
1,617 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension